The price of Cosmos Health Inc. (NASDAQ:COSM) shares last traded on Wall Street rose 0.75% to $1.34.
COSM stock price is now -23.47% away from the 50-day moving average and -67.34% away from the 200-day moving average. The market capitalization of the company currently stands at $17.82M.
In other news, Siokas Grigorios, Chief Executive Officer bought 181,451 shares of the company’s stock on Jul 20. The stock was bought for $449,998 at an average price of $2.48. Upon completion of the transaction, the Chief Executive Officer now directly owns 1,327,885 shares in the company, valued at $1.78 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jun 06, Chief Executive Officer Siokas Grigorios bought 4,474 shares of the business’s stock. A total of $107,018 was incurred on buying the stock at an average price of $23.92. This leaves the insider owning 1,146,434 shares of the company worth $1.54 million. A total of 26.00% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in COSM stock. A new stake in Cosmos Health Inc. shares was purchased by BELVEDERE TRADING LLC during the first quarter worth $120,000. SIMPLEX TRADING, LLC invested $77,000 in shares of COSM during the first quarter. In the first quarter, GROUP ONE TRADING, L.P. acquired a new stake in Cosmos Health Inc. valued at approximately $45,000. SUSQUEHANNA INTERNATIONAL GROUP, LLP acquired a new stake in COSM for approximately $42,000. BANK OF AMERICA CORP /DE/ purchased a new stake in COSM valued at around $34,000 in the second quarter. In total, there are 13 active investors with 0.20% ownership of the company’s stock.
A candlestick chart of Cosmos Health Inc. (NASDAQ: COSM) showed a price of $1.3600 on Wednesday morning. During the past 12 months, Cosmos Health Inc. has had a low of $0.99 and a high of $23.84. As of last week, the company has a debt-to-equity ratio of 0.20, a current ratio of 2.20, and a quick ratio of 1.90. The fifty day moving average price for COSM is $1.7153 and a two-hundred day moving average price translates $3.2596 for the stock.
The latest earnings results from Cosmos Health Inc. (NASDAQ: COSM) was released for Jun, 2023. The net profit margin was -85.20% and return on equity was -127.40% for COSM. The company reported revenue of $12.36 million for the quarter, compared to $13.21 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -6.4 percent.
Cosmos Health Inc.(COSM) Company Profile
Cosmos Health Inc. provides proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, cosmetics, nursery, health care and baby products, and medical devices. Its nutraceutical product portfolio includes Sky Premium Life and Mediterranation. The company serves wholesale pharmaceutical distributors and independent retail pharmacies. It operates in Greece, Germany, the United Kingdom, Italy, Denmark, Croatia, and Cyprus. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
